In response to the COVID-19 pandemic, researchers from the Massachusetts Institute of Technology have published a pair of studies in a COVID-19 special issue of the Harvard Data Science Review, freely available via open access, ...
May 19, 2020
0
2
Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising. The FDA approval for other uses would greatly reduce the time ...
May 5, 2020
0
18
Life in lockdown may not last forever but Bill Gates is probably right in saying we will not return to normal until a vaccine has been rolled out worldwide. This could be many months, if not years away.
Apr 27, 2020
0
2
(HealthDay)—Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S. Food and Drug Administration warned Americans on Friday.
Apr 27, 2020
0
5
Researchers say they've developed a low-cost swab test that can diagnose COVID-19 infections in about 45 minutes.
Apr 16, 2020
1
610
U.S. hospitals fed up with shortages of critical medicines—mostly generic drugs that aren't profitable—have banded together.
Jan 26, 2020
0
9
Particularly in the case of accelerated drug approvals and drugs for rare diseases (orphan drugs), the evidence available at the time of market access is often insufficient for the early benefit assessment of drugs. Often, ...
Jan 24, 2020
0
1
(HealthDay)—The U.S. approval and regulation processes for pharmaceutical agents have evolved during the last four decades, according to a study published in the Jan. 14 issue of the Journal of the American Medical Association.
Jan 15, 2020
0
0
How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was investigated and corresponding recommendations were developed by a working group of the Drug ...
Dec 18, 2019
0
1
Approved use of the prescription-strength fish oil drug Vascepa should be widened to include more patients at risk for heart attack and stroke, a U.S. Food and Drug Administration advisory panel recommended Thursday.
Nov 18, 2019
0
3
